Clinical Trials Browser

Unknown × spartalizumab × Tumor-Agnostic × Clear all

NCT03468751 2020-06-01

Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors

Phase 1 Unknown

Neoplasm Metastasis, Neoplasms

NCT03693326 2018-10-03

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Phase 2 Unknown

Neoplasms